About Aphria (CVE:APH)
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company's retail sales are primarily sold through the Company's online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. Its cannabis oil products will include Champlain, Rideau and Capilano. Its cannabis oil products will be available in approximately 60 milliliter bottles. Its subsidiaries include Pure Natures Wellness Inc., which is engaged in producing and selling medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in providing support services to veterans and first responders.
Industry, Sector and Symbol:
- Industry: N/A
- Sub-Industry: Cannabis
- Sector: N/A
- Symbol: CVE:APH
- CUSIP: N/A
- Web: www.aphria.com
- Trailing EPS: C$0.04
- Net Margins: 245.74%
- Return on Equity: 21.38%
- Return on Assets: 18.65%
- Outstanding Shares: 111,611,000
Frequently Asked Questions for Aphria (CVE:APH)
What is Aphria's stock symbol?
Aphria trades on the Canadian Venture Exchange (CVE) under the ticker symbol "APH."
When will Aphria make its next earnings announcement?
Where is Aphria's stock going? Where will Aphria's stock price be in 2017?
2 analysts have issued 1-year target prices for Aphria's shares. Their predictions range from C$7.50 to C$9.00. On average, they expect Aphria's share price to reach C$8.25 in the next twelve months. View Analyst Ratings for Aphria.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Africa Oil Corp (AOI), Sandstorm Gold Ltd (SSL), Parex Resources (PXT), Painted Pony Energy Ltd (PPY), Pure Multi Family Reit Lp Cad (RUF.UN), Intertain Group Ltd (AQT.P), Kaminak Gold (KAM), Roxgold (ROG), Tidewater Midstream & Infrastructure Ltd (TWM), Pure Multi-Family REIT LP (RUF.U), Lumina Copper Corp (LCC), Surge Energy (SGY), Leucrotta Exploration (LXE), OrganiGram Holdings (OGI), Blackbird Energy (BBI), Falcon Oil & Gas Ltd (FO), CanElson Drilling (CDI) and Atlantic Gold Corp (AGB).
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Victor Neufeld, Chairman of the Board, President, Chief Executive Officer
- Cole Cacciavillani, Co-Chairman of the Board, Founder
- John Cervini, Co-Chairman of the Board, Founder
- Carl A. Merton, Chief Financial Officer
- Gary Leong, Chief Scientific Officer
- Arlene Dickinson, Director
- Robert Kozlov, Director
- Dennis Staudt, Director
- Philip Waddington, Director
How do I buy Aphria stock?
Shares of Aphria and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
MarketBeat Community Rating for Aphria (CVE APH)MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Aphria (CVE:APH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||C$8.25|
Consensus Price Target History for Aphria (CVE:APH)
Analysts' Ratings History for Aphria (CVE:APH)
(Data available from 11/19/2015 forward)
|10/17/2017||Eight Capital||Boost Price Target||C$7.50 -> C$9.00|
|10/12/2017||Canaccord Genuity||Downgrade||Speculative Buy -> Hold||C$7.00 -> C$8.25|
|8/17/2017||AltaCorp Capital||Reiterated Rating||Speculative|
|2/7/2017||Dundee Securities||Boost Price Target||Buy||C$6.00 -> C$7.50|
|4/19/2016||Mackie||Reiterated Rating||Speculative Buy||C$2.25|
|3/23/2016||Clarus Securities||Reiterated Rating||Buy|
Earnings History for Aphria (CVE:APH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Aphria (CVE:APH)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Aphria (CVE:APH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Aphria (CVE APH)
Insider Trades by Quarter for Aphria (CVE APH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/9/2017||Dennis Joseph Staudt||Director||Sell||40,000||C$6.10||C$244,000.00|
Latest Headlines for Aphria (CVE APH)
Financials are not available for this stock.
Aphria (CVE APH) Chart for Sunday, November, 19, 2017